Celldex Therapeutics
CLDX
#4691
Rank
NZ$3.41 B
Marketcap
NZ$51.33
Share price
6.44%
Change (1 day)
13.11%
Change (1 year)

Celldex Therapeutics (CLDX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$86.83 Million

According to Celldex Therapeutics's latest financial reports the company's total liabilities are NZ$86.83 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Celldex Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$80.38 M39.44%
2023-12-31NZ$57.64 M37.95%
2022-12-31NZ$41.78 M13.36%
2021-12-31NZ$36.86 M0.44%
2020-12-31NZ$36.7 M-14.49%
2019-12-31NZ$42.92 M-9.32%
2018-12-31NZ$47.33 M-57.59%
2017-12-31NZ$0.11 B-34.45%
2016-12-31NZ$0.17 B145.41%
2015-12-31NZ$69.37 M49.51%
2014-12-31NZ$46.39 M39.66%
2013-12-31NZ$33.22 M-8.19%
2012-12-31NZ$36.18 M-3.52%
2011-12-31NZ$37.5 M-16.58%
2010-12-31NZ$44.96 M-50.96%
2009-12-31NZ$91.69 M3%
2008-12-31NZ$89.01 M549.01%
2007-12-31NZ$13.71 M-83.71%
2006-12-31NZ$84.19 M269.79%
2005-12-31NZ$22.76 M119.68%
2004-12-31NZ$10.36 M99.02%
2003-12-31NZ$5.2 M-29.91%
2002-12-31NZ$7.43 M-62.44%
2001-12-31NZ$19.78 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Seagen
SGEN
NZ$1.87 B 2,064.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$0.89 B 927.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$1.52 B 1,654.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$139.63 B 160,699.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$200.52 B 230,819.00%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$106.27 B 122,282.78%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
NZ$0.45 M-99.47%๐Ÿ‡บ๐Ÿ‡ธ USA